POU5F1 and kidney cancer: In contrast, using the PROGgeneV2 and OncoLnc database, the relationship between over-expression of OCT4 and low patient survival rates was confirmed in ovarian and kidney cancers (Fig. 2g,h; Supplementary Table S2).